AVITA Medical (RCEL) Profit After Tax (2018 - 2025)

AVITA Medical has reported Profit After Tax for 8 years, with the latest figure at -$11.6 million in Q4 2025.

• For the quarter ending Q4 2025, Profit After Tax changed 0.28% year-over-year to -$11.6 million; the trailing twelve-month figure through Dec 2025 stood at -$48.6 million (up 21.44% YoY), and the FY2025 full-year result was -$48.6 million, up 21.44% from the prior year.
• Profit After Tax for Q4 2025 stood at -$11.6 million, up from -$13.2 million in the prior quarter.
• The five-year high for Profit After Tax was -$4.7 million in Q2 2021, with the low at -$18.7 million in Q1 2024.
• Historically, Profit After Tax has averaged -$10.2 million across 5 years, with a median of -$9.7 million in 2022.
• Annual changes were most pronounced in 2021 — Profit After Tax surged 63.47% — and 2024, when it slumped 102.36%.
• AVITA Medical's Profit After Tax stood at -$5.9 million in 2021, then rose by 10.0% to -$5.4 million in 2022, then plunged by 31.98% to -$7.1 million in 2023, then tumbled by 64.03% to -$11.6 million in 2024, then fell by 0.28% to -$11.6 million in 2025.
• The last three Profit After Tax figures came in at -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025), per Business Quant data.